Skip to main content

Table 1 Datasets used in the case study differential analysis.

From: PathEx: a novel multi factors based datasets selector web tool

Experiment/Study Accession numbers Platform Source Availability Experimental conditions
E-GEOD-1323 HG-U133A AE Available 3 human colorectal cancer derived from a primary tumor VS. 3 corresponding lymph node metastases
E-GEOD-2280 HG-U133A AE Available 8 squamous cell carcinoma of the oral cavity VS. 19 corresponding lymph node metastases
E-MEXP-44 HG-U95Av2 AE Available 15 head and neck squamous cell carcinoma VS. 3 corresponding lymph node metastases
  HG-UgeneFL    12 head and neck squamous cell carcinoma VS. 11 corresponding lymph node metastases
GSE1056 HG-U95Av2 GEO Not available 2 human hepatocellular carcinoma under hypoxia for 2 hours VS. 2 control human hepatocellular carcinoma
2 human hepatocellular carcinoma under hypoxia for 24 hours VS. 2 control human hepatocellular carcinoma
GSE2280 HG-U133A GEO Available 22 squamous cell carcinoma of the oral cavity VS. 5 corresponding lymph node metastases
GSE2603 HG-U133A GEO Available 100 primary breast cancer VS. 21 lung metastases
GSE3325 HG-U133Plus2.0 GEO Available 7 primary prostate cancer VS. 6 metastases
GSE4086 HG-U133Plus2.0 GEO Available 2 human Burkitt's lymphoma under hypoxia VS. 2 control human Burkitt's lymphoma
GSE468 HC-G110 GEO Available 13 primary medulloblastomas VS. 10 metastatic medulloblastomas
GSE4840 HG-U133A GEO Not available 3 samples from normal melanocyte culture VS. 12 samples from culture of cutaneous metastasis of melanoma
  HG-U133B    3 samples from normal melanocyte culture VS. 12 samples from culture of cutaneous metastasis of melanoma
GSE4843 HG-U133Plus2.0 GEO Not available 45 samples from culture of cutaneous melanoma metastasis
GSE6369 HG-U133Plus2.0 GEO Available 1 primary prostate carcinoma VS. 1 metastatic prostate carcinoma
GSE6919 HG-U95Av2 GEO Available 65 primary prostate tumors VS. 25 metastatic prostate tumors
  HG-U95B    66 primary prostate tumors VS. 25 metastatic prostate tumors
  HG-U95C    65 primary prostate tumors VS. 25 metastatic prostate tumors
GSE7929 HG-U133A GEO Available 11 poorly metastatic melanoma VS. 21 highly metastatic melanoma
GSE7930 HG-U133A GEO Available 3 poorly metastatic prostate tumors VS. 3 highly metastatic prostate tumors
GSE7956 HG-U133A GEO Available 10 poorly metastatic melanoma VS. 29 highly metastatic melanoma
GSE8401 HG-U133A GEO Available 31 primary melanoma VS. 52 melanoma metastasis
  1. The above table shows the list of datasets drawn by the PathEx system automatically.